Enlitic Inc Lands First Australian Ensight Subscription With Lumus Imaging
Enlitic lands first Australian Ensight subscription with Lumus Imaging
Enlitic, Inc. (ASX: ENL) has signed a three-year Ensight subscription agreement with Lumus Imaging, a leading Australian diagnostic imaging provider. The deal is Enlitic’s first Ensight subscription in the Australian market, establishing a deployment within a major national imaging network.
The agreement carries a contract value of US$248,000 (~A$359,000) over its three-year term, with go-live expected during H2 2026. It positions Enlitic with a reference deployment inside a large national imaging network and supports the Company’s shift toward recurring SaaS revenue.
When big ASX news breaks, our subscribers know first
Full Ensight platform deployed across three use cases
Lumus will deploy the full Ensight platform from the outset across three distinct use cases, a signal of both platform breadth and growing customer demand. According to Enlitic, this multi-use-case adoption reflects demand for Ensight as a data infrastructure platform, rather than for data migration alone.
The three use cases are:
-
Hanging Protocols — standardises how imaging studies are presented to radiologists at the point of read
-
De-identification
-
AI validation
The enterprise pricing reflects the workflow, functionality and study-volume scope of each deployment, rather than site count alone.
Contract snapshot and Lumus profile
Lumus, formerly Healthcare Imaging Services, is an established Australian diagnostic imaging provider with more than 30 years of operating history. It operates 150 locations across Australia, supported by more than 2,000 healthcare professionals, and delivers a full range of imaging modalities including MRI, CT, ultrasound, mammography, X-ray, PET/CT and nuclear medicine.
| Metric | Detail |
|---|---|
| Contract type | Three-year Ensight subscription |
| Contract value | US$248,000 (~A$359,000) |
| Go-live | Expected H2 2026 |
| Customer | Lumus Imaging (formerly Healthcare Imaging Services) |
| Network scale | 150 locations, 2,000+ professionals, 30+ years history |
CEO Commentary
“Signing Lumus as our first Australian Ensight subscription customer is an important entry point into the Australian market. Lumus’s decision to adopt the full Ensight platform, across hanging protocols, de-identification and AI validation, shows both real demand for the technology and its breadth across core imaging workflows. This multi-year agreement provides a foundation to grow the relationship over time and directly supports our strategy of building recurring SasS revenue in the large medical imaging sector,” said Michael Sistenich, Chief Executive Officer of Enlitic.
How the OEM channel makes this repeatable
Lumus runs on Intelerad’s IntelePACS, so Enlitic can deploy through its existing integration with that platform.
Intelerad is one of eight global OEMs actively engaged with Enlitic’s offering. The integration was first deployed at RHCNZ Medical Imaging Group, New Zealand’s largest private radiology provider (see ASX announcement: 12 May 2026).
The Intelerad integration underpinning the Lumus deployment was first validated in production at RHCNZ Medical Imaging Group, New Zealand’s largest private radiology provider, where the initial use case centred on hanging protocols before a broader pipeline of Ensight applications was flagged for future rollout.
The Lumus agreement is the second enterprise deployment through the same integration, demonstrating the repeatability of Enlitic’s OEM channel.
The next major ASX story will hit our subscribers first
What it means for Enlitic’s SaaS transition
The agreement supports the Company’s transition from migration and services revenue toward a recurring SaaS model. It also provides a reference deployment for further enterprise subscriptions across Australia and the wider Asia Pacific region, while offering a foundation to grow the Lumus relationship over time within the large medical imaging sector.
The shift toward recurring SaaS revenue has been building across Enlitic’s recent contract activity, with earlier US hospital wins at institutions including Parkland Health structured to position the Ensight platform as a long-term data infrastructure partner rather than a one-off migration vendor.
Key strategic takeaways for investors include:
-
Australian market entry — the first Ensight subscription in the Australian market, opening a new national network
-
OEM repeatability — the second deployment through the Intelerad integration, lowering friction for future wins
-
Recurring revenue shift — reinforcing the move from one-off migration work toward recurring SaaS income
Ready to Learn More About Enlitic’s Ensight Platform and Australian Market Expansion?
Enlitic’s first Australian Ensight subscription with Lumus Imaging marks a significant milestone, securing a three-year, US$248,000 agreement across a 150-location national imaging network. The full-platform deployment across hanging protocols, de-identification, and AI validation underscores Ensight’s growing role as a core data infrastructure solution in the medical imaging sector.
Investors seeking to explore Enlitic’s broader strategy, recurring SaaS pipeline, and OEM channel growth can visit the Enlitic investor centre for the latest company updates and announcements.